EUVIMEDEUVIMED entdecken
Leserbrief

Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate

Richard J Buka, David J Sutton, Phillip Lr Nicolson

Journal of Thrombosis and Thrombolysis · 2024

DOI: 10.1007/s11239-024-02948-5 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2024. Verfasst von Richard J Buka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. r.j.buka@bham.ac.uk. Hauptthemen laut MEDLINE: Factor Xa Inhibitors, Veterans, Blood Coagulation Factors. Die Arbeit nennt 8 Literaturangaben. Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor Xa InhibitorsVeteransBlood Coagulation FactorsHumansEnoxaparinFactor XaHemorrhageRecombinant ProteinsAnticoagulants

Substanzen

Factor Xa Inhibitorsprothrombin complex concentratesEnoxaparinPRT064445Factor XaRecombinant ProteinsAnticoagulantsBlood Coagulation Factors

Autor:innen und Institutionen

  • Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. r.j.buka@bham.ac.uk.
  • Staffordshire Thrombosis and Anticoagulation Service, University Hospitals North Midlands NHS Trust, Stoke-on-Trent, UK.
  • Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
  • Department of Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Förderung

  • British Heart Foundation

Zitieren

APA

Buka, R. J., Sutton, D. J., & Nicolson, P. L. (2024). Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-024-02948-5

Vancouver

Buka RJ, Sutton DJ, Nicolson PL. Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. Journal of Thrombosis and Thrombolysis. 2024. doi:10.1007/s11239-024-02948-5

BibTeX
@article{Buka2024,
  author = {Buka, Richard J and Sutton, David J and Nicolson, Phillip Lr},
  title = {Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2024},
  doi = {10.1007/s11239-024-02948-5}
}
Kostenlos starten →